Desoxycorticosterone Acetate
(VPGRYOFKCNULNK-ACXQXYJUSA-N)
Structure
- SMILES
- CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
- Type(s)
- Approved
- Molecular Formula:
- C23H32O4
- Molecular Weight:
- 372.498
- Log P:
- 4.2667
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 0
- TPSA:
- 60.44
- CAS Number(s):
- 56-47-3
Synonym(s)
1.
Desoxycorticosterone Acetate
2.
DOCA
3.
DOC-21-acetate
4.
Deoxycorticosterone-21-acetate
5.
Desoxycorticosterone-21-acetate
6.
Desoxycortone Acetate
7.
Syncortyl
8.
Acetate, Desoxycortone
9.
DOC 21 acetate
10.
Deoxycorticosterone 21 acetate
11.
Desoxycorticosterone 21 acetate
External Link(s)
| MeSH | D064791 |
| PubChem Compound | 5952 |
| ChEBI | 34671 |
| CHEMBL | CHEMBL1200542 |
| DrugBank | DB06780 |
| DrugCentral | 821 |
| KEGG | cpd:C14554 dr:D03698 |
| ZINC | 4428527 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Albuminuria | 30290168 | CTD | |
| 2 | Cardiomegaly | 30290168 | CTD | |
| 3 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Endomyocardial Fibrosis | 30290168 | CTD | |
| 5 | Hypertrophy | 7721389 | CTD | |
| 6 | Insulin Resistance | 23089228 | CTD | |
| 7 | Kidney Diseases | 18504326 | CTD | |
| 8 | Nephrosclerosis | 30290168 | CTD | |
| 9 | Pruritus | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Vascular Remodeling | 27678262 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.